Tech News
← Home  ·  All topics

Eye Diseases

1 GoKawiil brief on this topic · RSS for eye diseases

Johnson & Johnson to acquire Ollin Biosciences for $2.2 billion

Johnson & Johnson has agreed to purchase Ollin Biosciences, a clinical-stage biopharmaceutical company focused on treatments for serious eye diseases, in a deal valued at $2.2 billion. The acquisition would bring Ollin's pipeline of ophthalmology therapies under J&J's umbrella.